These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 13910592)

  • 1. [On antitrypsin therapy of pancreatopathies and pancreatitis states in upper abdominal diseases].
    SEMMLER F
    Med Welt; 1962 Jul; 28():1523-4. PubMed ID: 13910592
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in therapy of inflammatory diseases of the pancreas. Peroperative and postoperative protection with inhibitory substances as a prophylaxis against pancreatitis and pancreatic necrosis].
    ASANG E
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1960; 294():83-102. PubMed ID: 13794634
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trasylol treatment in inflammatory pancreatic diseases].
    BALG KH; LIESER H
    Med Welt; 1961 Oct; 42():2175-7. PubMed ID: 13864369
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of pancreatic diseases].
    GRIESSMANN H
    Med Welt; 1962 Jun; 23():1287-90. PubMed ID: 13901811
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in the therapy of inflammatory diseases of the pancreas. A report on 1 year of therapy and prophylaxis with the kallikrein- and trypsin inactivator trasylol (Bayer)].
    ASANG E
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1960; 293():645-70. PubMed ID: 13794633
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the use of the kallikrein-trypsin inactivator "Trasylol" in acute pancreatitis and similar disease states].
    KYRLE P
    Wien Klin Wochenschr; 1962 Jan; 74():5-9. PubMed ID: 14461137
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy with kallikrein and trypsin inhibitors, a part of the modern treatment of acute pancreatitis].
    CRAMER W; SEELIGER FG
    Zentralbl Chir; 1961 Mar; 86():914-23. PubMed ID: 13696241
    [No Abstract]   [Full Text] [Related]  

  • 8. [The kallikrein inactivator and trypsin ("Trasylol") in the treatment of acute pancreati steatonecrosis].
    BAGUENA CANDELA R
    Med Esp; 1962 May; 47():394-9. PubMed ID: 13863955
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of pancreatitis with anti-enzymes. (Apropos of 5 cases)].
    BRETTE R; THIVOLET J; TISSOT A
    Lyon Med; 1962 May; 94():1231-44. PubMed ID: 13872942
    [No Abstract]   [Full Text] [Related]  

  • 10. [Considerations on the use of an enzymatic inactivator in the treatment of a case of acute pancreatitis].
    SCALVINI L
    Arch Med Interna; 1961; 13():29-36. PubMed ID: 14497774
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of acute pancreatic steatonecrosis treated with an inactivator of trypsin and kallikrein].
    HERNANDEZ SANCHEZ BARBA A
    Rev Esp Enferm Apar Dig Nutr; 1962 Feb; 21():339-42. PubMed ID: 13906751
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of acute pancreatitis with anti-enzymes. (Apropos of 12 cases)].
    BERTRAND P; GIRARD M; BEL A; POUYET M; LOMBARD-PLATET R
    Lyon Med; 1962 May; 94():1205-20. PubMed ID: 13868519
    [No Abstract]   [Full Text] [Related]  

  • 13. [Modification of excretory pancreatic function by kallikrein inhibitor (trasylol)].
    MUELLER-WIELAND K
    Dtsch Z Verdau Stoffwechselkr; 1961 Apr; 21():1-6. PubMed ID: 13773582
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relations between digestive ulcers and chronic pancreatitis. Digestive ulcers in lipomatosis of the pancreas. Toward an extension of the Zollinger-Ellison syndrome. Apropos of some personal findings].
    LEGER L; DETRIE P; RANTY J
    Presse Med (1893); 1960 Nov; 68():1830-2. PubMed ID: 13760371
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the antifibrinolytic effect of trypsin--kallikrein inactivator].
    STEICHELE DF; HERSCHLEIN HJ
    Med Welt; 1961 Oct; 42():2170-2. PubMed ID: 13916580
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental data on the efficacy of the kallikrein-trypsin inactivator (Trasylol)].
    GUELZOW M; TRETTIN HJ; DIWOK K
    Klin Wochenschr; 1961 Jun; 39():597-8. PubMed ID: 13709414
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical observations on the treatment and prevention of pancreatitis and postoperative pancreatic damage].
    MAURER W
    Chirurg; 1962 Jul; 33():297-300. PubMed ID: 14471563
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pancreatic lesions and digestive ulcers].
    LEGER L; DETRIE P
    Mem Acad Chir (Paris); 1960 Mar 6-Apr 30; 86():406-9. PubMed ID: 14415298
    [No Abstract]   [Full Text] [Related]  

  • 19. The importance of the pancreatic factor in early relapse of peptic ulcer.
    MARCONI R; CRAVERO D
    Panminerva Med; 1961 Sep; 3():428-32. PubMed ID: 14469680
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effects of trypsin inhibitors on blood coagulation].
    BENZER H; BLUMEL G; PIZA F
    Wien Med Wochenschr; 1960 Jul; 110():609-12. PubMed ID: 13799068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.